Catalyst, KYE Announce Canadian Federal Court Ruling on Approval of Ruzurgi
11 Mar 2022 //
GLOBENEWSWIRE
KYE Pharmaceuticals Announces Approval of CORZYNA™ in Canada
05 Jan 2021 //
NEWSWIRE
11 Mar 2022 //
GLOBENEWSWIRE
05 Jan 2021 //
NEWSWIRE